Kato H, Yokoe N, Takemura S, Yoshikawa T, Furukawa Y, Kondo M
Res Exp Med (Berl). 1983;182(2):85-94. doi: 10.1007/BF01851114.
A protein-bound polysaccharide from mycelia of Coriolus versicolor PS-K, clinically used as an immunomodulator, has been shown to restore the decreased cellular immune response and to exhibit host-mediated antitumor activity. In this experiment, PS-K was found to increase serum complement level in guinea pig and in human without malignancy, when hemolytic assay of complement was performed using sensitized sheep erythrocytes for the classical pathway activity and unsensitized rabbit erythrocytes for the alternative pathway activity. Assay of complement components revealed increase in C3 level in guinea pig, but no significant changes in C1q, C4, C3, properdin, C3 activator, and C1-inhibitor in human, while C5 and C9 were depressed. Conversion of beta 1C to beta 1A was observed in the 7th day's plasma of these patients by crossed immunoelectrophoresis. Biosynthesis of guinea pig C3 was accelerated by administration of PS-K, but that of C4 was not affected. These evidences suggested that PS-K might potentiate immune response of the host by elevating serum complement level, in addition to the activation of the complement system.
云芝PS-K菌丝体中的一种蛋白结合多糖,临床上用作免疫调节剂,已被证明可恢复降低的细胞免疫反应并表现出宿主介导的抗肿瘤活性。在本实验中,当使用致敏绵羊红细胞进行经典途径活性的补体溶血试验以及使用未致敏兔红细胞进行替代途径活性的补体溶血试验时,发现PS-K可提高豚鼠和无恶性肿瘤的人的血清补体水平。补体成分分析显示豚鼠的C3水平升高,但人的C1q、C4、C3、备解素、C3激活剂和C1抑制剂无显著变化,而C5和C9降低。通过交叉免疫电泳在这些患者第7天的血浆中观察到β1C向β1A的转化。给予PS-K可加速豚鼠C3的生物合成,但对C4的生物合成无影响。这些证据表明,PS-K除了激活补体系统外,还可能通过提高血清补体水平来增强宿主的免疫反应。